Chase Investment Counsel’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-24,000
Closed -$2.34M 132
2025
Q3
$2.34M Hold
24,000
0.69% 44
2025
Q2
$1.67M Hold
24,000
0.53% 47
2025
Q1
$1.19M Buy
24,000
+9,000
+60% +$569K 0.44% 62
2024
Q4
$1.05M Buy
+15,000
New +$1.25M 0.34% 71

Other funds holding ACLS

Chase Investment Counsel's ACLS Position: Q4 2025 in Review

Chase Investment Counsel sold out of Axcelis (ACLS) in Q4 2025, closing a stake of 24,000 shares — an estimated $2.34M sold.

Chase Investment Counsel first reported a position in ACLS in Q4 2024 and held it in 4 quarters. The position peaked at $2.34M in Q3 2025. 370 funds tracked by Wall St. Rank hold ACLS as of Q4 2025.

  • Chase Investment Counsel reported no remaining Axcelis position as of Q4 2025 after selling out during the quarter.
  • Chase Investment Counsel sold 24,000 Axcelis shares in Q4 2025, an estimated $2.34M.
  • Chase Investment Counsel first reported a position in Axcelis in Q4 2024 and held it in 4 quarters.
  • Chase Investment Counsel's Axcelis position peaked at $2.34M in Q3 2025.
  • 370 funds tracked by Wall St. Rank held Axcelis as of Q4 2025.

Based on Chase Investment Counsel's 13F filing for Q4 2025, filed 5 Feb 2026.